Lotte Chemical Discloses Governance Report: Neutral Impact Amid Ongoing Losses, Spin-off Plan, and Maintained Shareholder Returns
Lotte Chemical posted 2025 revenue of KRW 18.48 trillion, operating loss of KRW 943.1 billion, and net loss of KRW 2.48 trillion, marking a third consecutive year of losses and continued financial deterioration
Pursuing financial health improvement and liquidity through asset sales including partial disposal of PT LCI (Indonesia) and sale of LOTTE Chemical Pakistan shares
Extraordinary shareholders' meeting in April 2026 approved the physical spin-off of the Daesan plant; shortened meeting notice period under the Special Act on Corporate Revitalization raised concerns over minority shareholder rights
Final dividend of KRW 500 per share and interim dividend totaling KRW 1,000 per share (approx. KRW 42.1 billion), representing a 71% decrease from 2023
Completed KRW 50 billion share buyback (608,272 shares) under the 2022-2026 mid-to-long-term shareholder return policy; no additional buyback during the period
Amended articles of incorporation at the 50th AGM to abolish exclusion of cumulative voting and mandate e-shareholder meetings; hybrid online-offline meetings planned from 2027
Non-compliance with some key governance indicators: failure to provide 4-week advance notice for shareholder meetings, and lack of explicit consent rights over audit committee support staff personnel changes
Strengthened board independence and oversight: majority of outside directors (5 of 9), all outside directors on audit and compensation committees, introduction of lead outside director system
Maintained ISO 37001/37301 integrated certification for compliance management system, operated compliance officer and disclosure management regulations, received unqualified opinion on internal accounting controls
[AI Summary]Lotte Chemical continues governance improvements and shareholder return policies such as dividends and buybacks, but persistent large losses, potential minority shareholder rights restrictions during restructuring (Daesan spin-off), sharp dividend cuts, and lack of a disclosed value-up plan suggest underlying neutral investment risk with concerns over shareholder value erosion